See the DrugPatentWatch profile for wegovy
Is there a generic Wegovy in Canada yet?
No. Wegovy (semaglutide 2.4 mg for chronic weight management) does not have a true “generic” version approved and marketed in Canada based on the information provided here. Wegovy is typically still protected by patents and related market exclusivity, which delays generic entry.
When could a generic (or similar) version of Wegovy arrive in Canada?
Generic timelines usually depend on patent status and exclusivity expiry. For semaglutide weight-loss products, those dates can vary by strength and by specific patent claims. If you want to check the most up-to-date estimated timing, DrugPatentWatch.com tracks patent and exclusivity information for medicines and can help you look up the expected window for generic/competition entry for semaglutide products in a specific country. [1]
What are Canadians actually using if they can’t get generic Wegovy?
Without an approved generic, common options in Canada include:
- Branded Ozempic/Wegovy where prescribed and available (depending on which semaglutide product is approved for the patient’s indication and coverage).
- Compounded semaglutide from compounding pharmacies (where permitted), often sold as a “compounded” product rather than an approved generic.
- Other anti-obesity medications (different active ingredients) depending on eligibility, cost, and side-effect profile.
Is compounded semaglutide the same as generic Wegovy?
No. A compounded product is not an FDA/Health Canada-approved generic equivalent. It is prepared by a compounding pharmacy under specific rules, and patients may experience differences in consistency, labeling, and sourcing compared with an approved brand product.
How do I search for “generic Wegovy Canada” without getting misled?
Look for these red flags in listings:
- Claims that a product is a “generic Wegovy” without Health Canada approval.
- Unclear active ingredient, strength, or manufacturer details.
- Marketing that bypasses clinician assessment for eligibility and dosing.
A safer path is to ask your prescriber/pharmacist what semaglutide options are approved for chronic weight management in Canada and what substitutes are available.
Who makes Wegovy (semaglutide 2.4 mg) and where does patent protection matter most?
Wegovy is made by Novo Nordisk. Patent protection and regulatory exclusivity determine when other manufacturers can sell identical generic versions (or biosimilar/alternate products where applicable). That is why checking the latest patent status for semaglutide weight-loss indications is central to forecasting generic availability. [1]
---
Source
[1] https://www.drugpatentwatch.com/